{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["17(11)"],"submitter":["Baumert BG"],"funding":["Cancer Research UK","Medical Research Council","NCI NIH HHS","National Health and MRC project grant","Canadian Cancer Society Research Institute"],"journal":["The Lancet. Oncology"],"pagination":["1521-1532"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5124485"],"repository":["biostudies-literature"],"pubmed_title":["Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study."],"pmcid":["PMC5124485"],"funding_grant_id":["MC_UU_12023/10","MC_U122861383","6850","U10 CA011488","MC_UU_12023/20","ID 509094","grant number 015469 and 021039","MC_UU_12023/28"],"pubmed_authors":["Thiessen B","Dhermain F","Kantor G","Bravo-Marques J","Rees J","Reni M","Gijtenbeek JMM","Clement PM","Rossiter JP","Kros JM","Feuvret L","Mason WP","Hoang-Xuan K","Brandes AA","Chinot O","Reijneveld JC","Dif N","Enting R","van den Bent MJ","von Deimling A","Hassel MB","Hartmann C","Hegi ME","Capper D","Kurscheid S","Lacombe D","Balana C","Tzuk-Shina T","Baumert BG","Wick W","Stupp R","Taphoorn MJB","Marosi C","Gorlia T","Bromberg JE","Nordal RA","Ryan G"],"additional_accession":[]},"is_claimable":false,"name":"Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.","description":null,"dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 Nov","modification":"2026-05-03T02:18:01.339Z","creation":"2025-02-19T00:46:37.772Z"},"accession":"S-EPMC5124485","cross_references":{"pubmed":["27686946"],"doi":["10.1016/S1470-2045(16)30313-8"]}}